Utility of radiotherapy for treatment of basal cell carcinoma: A review

British Journal of Dermatology

Volumn 171, Issue 5, 2014, Pages 968-973

  Cho, M ^a   Gordon, L ^b   Rembielak, A ^c   Woo, T C S ^d  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

^c CHRISTIE HOSPITAL   (United Kingdom)

^d Riverina Cancer Care Centre   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALOPECIA; BASAL CELL CARCINOMA; BONE NECROSIS; CANCER RADIOTHERAPY; CATARACT; CRYOTHERAPY; DRUG DOSE REGIMEN; DRY EYE; EPIPHORA; HUMAN; INTERMETHOD COMPARISON; MEDLINE; RADIATION DOSE; REVIEW; SKIN ATROPHY; SKIN CARCINOMA; SKIN FIBROSIS; SKIN NECROSIS; SKIN PIGMENTATION; SYSTEMATIC REVIEW; TELANGIECTASIA; ADVERSE EFFECTS; CARCINOMA, BASAL CELL; RETROSPECTIVE STUDY; SKIN NEOPLASMS; TREATMENT OUTCOME;

CARCINOMA, BASAL CELL; HUMANS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84911378332     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13253     Document Type: Review

References (30)

1. International Agency for Research on Cancer (IARC). Cancer Incidence in Five Continents. Lyon: IARC, 2002.
2. Staples M, Marks R, Giles G,. Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect? Int J Cancer 1998; 78: 144-8.
3. Australian Institute of Health and Welfare. Australian Cancer Incidence and Mortality Books. Available at: http://www.aihw.gov.au/acim-books/ (last accessed 9 September 2014).
4. Clark CM, Furniss M, Mackay-Wiggan JM,. Basal cell carcinoma: an evidence-based treatment update. Am J Clin Dermatol 2014; 15: 197-216.
5. Barrett A, Dobbs J, Morris S, Roques T,. Practical Radiotherapy Planning, Vol. 4. London: Hodder Arnold, 2009.
6. Krema H, Herrmann E, Albert-Green A, et al,. Orthovoltage radiotherapy in the management of medial canthal basal cell carcinoma. Br J Ophthalmol 2013; 97: 730-4.
7. Cognetta AB, Howard BM, Heaton HP, et al,. Superficial x-ray in the treatment of basal and squamous cell carcinomas: a viable option in select patients. J Am Acad Dermatol 2012; 67: 1235-41.
8. van Hezewijk M, Creutzberg CL, Putter H, et al,. Efficacy of a hypofractionated schedule in electron beam radiotherapy for epithelial skin cancer: analysis of 434 cases. Radiother Oncol 2010; 95: 245-9.
9. Swanson EL, Amdur RJ, Mendenhall WM, et al,. Radiotherapy for basal cell carcinoma of the medial canthus region. Laryngoscope 2009; 119: 2366-8.
10. Olschewski T, Bajor K, Lang B, et al,. [Radiotherapy of basal cell carcinoma of the face and head: importance of low dose per fraction on long-term outcome]. J Dtsch Dermatol Ges 2006; 4: 124-30.
11. Kwan W, Wilson D, Moravan V,. Radiotherapy for locally advanced basal cell and squamous cell carcinomas of the skin. Int J Radiat Oncol Biol Phys 2004; 60: 406-11.
12. Zagrodnik B, Kempf W, Seifert B, et al,. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Cancer 2003; 98: 2708-14.
13. Huynh NT, Veness MJ,. Basal cell carcinoma of the lip treated with radiotherapy. Australas J Dermatol 2002; 43: 15-19.
14. Avril MF, Auperin A, Margulis A, et al,. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 1997; 76: 100-6.
15. Silva JJ, Tsang RW, Panzarella T, et al,. Results of radiotherapy for epithelial skin cancer of the pinna: the Princess Margaret Hospital experience, 1982-1993. Int J Radiat Oncol Biol Phys 2000; 47: 451-9.
16. Abbatucci JS, Boulier N, Laforge T, Lozier JC,. Radiation therapy of skin carcinomas: results of a hypofractionated irradiation schedule in 675 cases followed more than 2 years. Radiother Oncol 1989; 14: 113-19.
17. Hall VL, Leppard BJ, McGill J, et al,. Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy. Clin Radiol 1986; 37: 33-4.
18. Fitzpatrick PJ, Thompson GA, Easterbrook WM, et al,. Basal and squamous cell carcinoma of the eyelids and their treatment by radiotherapy. Int J Radiat Oncol Biol Phys 1984; 10: 449-54.
19. Petit JY, Avril MF, Margulis A, et al,. Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face. Plast Reconstr Surg 2000; 105: 2544-51.
20. Hall JE, Giaccia AJ,. Radiobiology for the Radiologist, Vol. 7. Philadelphia: Lippincott Williams & Wilkins, 2011.
21. Kim JJ, Tannock IF,. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer 2005; 5: 516-25.
22. American Cancer Society. Second cancers caused by cancer treatment. Available at: http://www.cancer.org/acs/groups/cid/documents/webcontent/002043-pdf.pdf (last accessed 9 September 2014).
23. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Basal Cell and Squamous Cell Skin Cancers. Fort Washington: NCCN, 2013.
24. Lear W, Mittmann N, Barnes E, et al,. Cost comparisons of managing complex facial basal cell carcinoma: Canadian study. J Cutan Med Surg 2008; 12: 82-7.
25. Smeets NW, Krekels GA, Ostertag JU, et al,. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 2004; 364: 1766-72.
26. Mosterd K, Krekels GA, Nieman FH, et al,. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol 2008; 9: 1149-56.
27. Rowe DE, Carroll RJ, Day CL Jr,. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989; 15: 315-28.
28. Kopf AW, Bart RS, Schrager D, et al,. Curettage-electrodesiccation treatment of basal cell carcinomas. Arch Dermatol 1977; 113: 439-43.
29. Rhodes LE, de Rie M, Enström Y, et al,. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 2004; 140: 17-23.
30. Gollnick H, Barona CG, Frank RG, et al,. Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe. Eur J Dermatol 2005; 15: 374-81.